Hospira Vincristine Sulfate Injection USP 1 mg/1 mL Vial

Krajina: Austrália

Jazyk: angličtina

Zdroj: Department of Health (Therapeutic Goods Administration)

Aktívna zložka:

vincristine sulfate, Quantity: 1 mg/mL

Dostupné z:

Hospira Australia Pty Ltd

INN (Medzinárodný Name):

Vincristine sulfate

Forma lieku:

Injection

Zloženie:

Excipient Ingredients: mannitol; water for injections; sodium hydroxide; sulfuric acid

Spôsob podávania:

Intravenous

Počet v balení:

1 x 2 mL vial

Trieda:

Medicine Listed (Export Only)

Typ predpisu:

(S1) This Schedule is intentionally blank

Terapeutické indikácie:

Vincristine sulfate injection is indicated in acute leukemia. Vincristine sulfate injection has also been shown to be useful in combination with other oncolytic agents in Hodgkin's disease, non-Hodgkin's malignant lymphomas, rhabdomyosarcoma, neuroblastoma, and Wilm's tumor.

Prehľad produktov:

Visual Identification: A clear, colourless solution.; Container Type: Vial; Container Material: Glass Type I Clear; Container Life Time: 18 Months; Container Temperature: Store at 2 to 8 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

Stav Autorizácia:

Licence status A

Dátum Autorizácia:

2007-07-16